This content is from: Research It’s Been One Year Since Covid-19 Arrived in China. These Are the Research Firms That Got Investors Through It. China International Capital Corp. and Huatai Securities lead the 2020 All-China Research Team. By Alexandra DeLuca December 09, 2020
This content is from: Research CICC’s Reign Continues in Chinese Equity Sales China International Capital Corp. stayed on top of II’s All-China Sales Team in a “volatile and eventful” year for Chinese equities. By Alexandra DeLuca November 06, 2019
This content is from: Research In A Year Dominated By Covid-19, These Sales Teams Led the Way Chinese markets were the first crippled by the coronavirus pandemic. Here’s how the All-China Sales Team responded. By Alexandra DeLuca December 09, 2020
This content is from: Portfolio Investors’ Preference for Later Stage Tech Deals During the Pandemic is Expected to Continue Rising competition and deal prices “increase the odds of missteps” for corporations looking to expand through tech start-ups, according to Bain & Company. By Jessica Hamlin September 27, 2021
Sponsored Is Now the Time for China A-shares? An experienced local eye sees all the pieces falling into place for a potentially significant growth story. Sponsored by Mackenzie Investments April 30, 2020
This content is from: Research In ‘Challenging’ Year, CICC Leads Chinese Equity Sales Both international and domestic investors chose China International Capital Corp. as the No. 1 firm in II’s 2018 All-China Sales Team. By Alexandra DeLuca November 06, 2018
